| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8433084 | Cancer Epidemiology | 2016 | 7 Pages |
Abstract
Unless contraindicated, efforts to ensure receipt of ACT for stage III colon cancer patients up to 84 years of age are needed to improve the prognosis of patients with node-positive disease.
Keywords
RCTPropensity score weightingPSWACTSMRMultivariable modelingFolfoxPSMRandomized controlled trialStandardizedSurvivalPropensity score matchingTreatmentMethodologyPerson-yearsColon cancerAdjuvant chemotherapyconfidence intervalCensus tractMortality ratehazard ratiostandardized mortality ratioPropensity scoreKaplan-MeierQuality
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Robert B. PhD, Milan PhD, Asal M. PhD, A. Rana MPH, Tracie C. MD MPH,